Comments for Stephen Tuck Solutions Blog

Comment on The Egg of the Chicken by souzachicken

souzachicken — Tue, 05 Jan 2010 11:55:26 +0000

Souza Chicken is a largest suppliers and Exporters of chicken, Broiler chicken, fresh chicken, chicken products and hatching eggs in Mangalore India.

Comment on European H1N1 Vaccine Latecomers Herald the Regulatory Acceptance of Innovation by European H1N1 Vaccine Latecomers Herald the Regulatory Acceptance of Innovation | H1N1INFLUENZAVIRUS.US

Mon, 21 Dec 2009 10:56:40 +0000

[...] antigens which have traditionally been produced in embryonated hens’ eggs…. Read more: European H1N1 Vaccine Latecomers Herald the Regulatory Acceptance of Innovation Posted in H1N1 Flu, Influenza Virus. Tags: a-has-been, a-virus-antigens, antigens-which, [...]

Comment on Celvapan: Cell-Culture H1N1 Vaccine Approved by European H1N1 Vaccine Latecomers Herald the Regulatory Acceptance of Innovation « Stephen Tuck Solutions Blog

Mon, 21 Dec 2009 02:46:25 +0000

[...] differentiated from Focetria and Pandemrix through its cell-culture based production technology. As described previously in this blog, Novartis has a validated cell-culture process for production of influenza virus antigens which [...]

Comment on EMEA Approves Adjuvanted H1N1 Vaccines by European H1N1 Vaccine Latecomers Herald the Regulatory Acceptance of Innovation « Stephen Tuck Solutions Blog

Mon, 21 Dec 2009 02:46:09 +0000

[...] authorise the product, effectively resulting in a marketing authorisation for all 27 countries. As discussed in earlier blog entries the vaccines were all granted authorizations under strain change variances to their original [...]

Comment on HHS Backs A Recombinant Baculovirus H1N1 Vaccine by Recombinant Seasonal Flu Vaccine « Stephen Tuck Solutions Blog

Recombinant Seasonal Flu Vaccine « Stephen Tuck Solutions Blog — Tue, 15 Dec 2009 01:30:46 +0000

[...] Protein Sciences’ Flublok, an investigational seasonal recombinant influenza vaccine, which has been discussed before on this blog, is the nearest thing to an approved recombinant vaccine in the US. It is produced in insect [...]

Comment on UK’s H1N1 Vaccine in August by Autism and Vaccines Vaccinations

Autism and Vaccines Vaccinations — Fri, 27 Nov 2009 14:17:45 +0000

I found your blog on google and read a few of your other posts. I just added you to my Google News Reader. Keep up the good work. Look forward to reading more from you in the future.

Comment on EMEA Approves Adjuvanted H1N1 Vaccines by GSK’s H1N1 Vaccine: A Split Personality « Stephen Tuck Solutions Blog

GSK’s H1N1 Vaccine: A Split Personality « Stephen Tuck Solutions Blog — Thu, 12 Nov 2009 20:55:54 +0000

[...] As described here in earlier blogs about the European pandemic vaccine approval process, Canada employed the mock vaccine approach, developing an H5N1 vaccine in the pre-pandemic period. Health Canadainspected the antigen manufacturing facilities, evaluated data from the process, and reviewed both animal and human data from studies performed with the mock vaccine. Safety and effectiveness of the AS03 adjuvant was also evaluated and deemed acceptable. [...]

Comment on HHS Purchases More MedImmune H1N1 Vaccine by GSK’s H1N1 Vaccine: A Split Personality « Stephen Tuck Solutions Blog

GSK’s H1N1 Vaccine: A Split Personality « Stephen Tuck Solutions Blog — Thu, 12 Nov 2009 20:54:50 +0000

[...] order was for $38 million of vaccine, suggesting a cost of $5 for each of the 7.6 million doses. As discussed in this blog on September 21st, this is in line with the $5.30 per dose paid for the 75.3 million doses contracted from Sanofi, [...]

Comment on Phase 6 Influenza Pandemic Announced and a Prototype H1N1 Vaccine Arrives on Schedule by Celvapan: Cell-Culture H1N1 Vaccine Approved « Stephen Tuck Solutions Blog

Celvapan: Cell-Culture H1N1 Vaccine Approved « Stephen Tuck Solutions Blog — Mon, 19 Oct 2009 23:47:14 +0000

[...] cell-line derived from the kidney epithelial cells of African green monkeys. As described in this Blog on June 12th, only about 5% of the world’s current manufacturing capacity is cell-culture based. Baxter [...]

Comment on Adjuvanted H1N1 Vaccine from GSK by EMEA Approves Adjuvanted H1N1 Vaccines « Stephen Tuck Solutions Blog

EMEA Approves Adjuvanted H1N1 Vaccines « Stephen Tuck Solutions Blog — Wed, 07 Oct 2009 18:40:00 +0000

[...] discussed on this blog back on May 18th, an adjuvant may become mandatory for translating the available flu vaccine manufacturing capacity [...]